Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients.

about

Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients.

Item

http://www.wikidata.org/entity/Q39030017

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluation of safety and effec ...... ese versus non-obese patients.

@en

Evaluation of safety and effec ...... ese versus non-obese patients.

@nl

type

Item

label

Evaluation of safety and effec ...... ese versus non-obese patients.

@en

Evaluation of safety and effec ...... ese versus non-obese patients.

@nl

prefLabel

Evaluation of safety and effec ...... ese versus non-obese patients.

@en

Evaluation of safety and effec ...... ese versus non-obese patients.

@nl

P1476

Evaluation of safety and effec ...... ese versus non-obese patients.

@en

P2093

Angela L Bingham

http://www.w3.org/2001/XMLSchema#string

James M Hollands

http://www.w3.org/2001/XMLSchema#string

Krystal Hunter

http://www.w3.org/2001/XMLSchema#string

Laura A Siemianowski

http://www.w3.org/2001/XMLSchema#string

Manuel Isherwood

http://www.w3.org/2001/XMLSchema#string

Michelle L Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism

Prevalence of childhood and adult obesity in the United States, 2011-2012

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.

Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.

Comparison of heparin dosing based on actual body weight in non-obese, obese and morbidly obese critically ill patients.

Safety and efficacy of the use of institutional unfractionated heparin protocols for therapeutic anticoagulation in obese patients: a retrospective chart review.

Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients.

Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin.

Evaluation of weight-based dosing of unfractionated heparin in obese children.

Weight-based heparin protocol using antifactor Xa monitoring.

P2888

s11239-016-1466-9

P304

476-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-016-1466-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28070821

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas